Latest Breaking News On - Moran meir - Page 1 : comparemela.com

BioLineRx Announces Clinical Trial Agreement with St Jude Children s Research Hospital, Inc to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD)

BioLineRx Announces Clinical Trial Agreement with St Jude Children s Research Hospital, Inc to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesElla soraniMoran meirJohn laceyJude children research hospitalBiolinerx ltdUs food drug administrationExchange commission onPrnewswire biolinerx ltdWashington university school of medicineJude children research hospital incLifesci advisorsJude childrenResearch hospitalChief development officerWashington university school

BioLineRx : Reports First Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER .

United statesIsrael generalPhilip serlinTwitterand linkedinPhilipa serlinGloria biosciencesMoran meirJohn laceyGloria bioscienceExchange commission onMedicaid servicesLifesci advisorsWashington university in stInternational society for pharmacoeconomicsOutcomes research onAmerican society of clinical oncology

BioLineRx to Report First Quarter 2024 Results on May 28, 2024

Management to Hold Conference Call at 8:30 a.m. EDT TEL AVIV, Israel, May 22, 2024 /PRNewswire/ BioLineRx Ltd. , a commercial stage biopharmaceutical company pursuing life-changing therapies in.

United statesPhilip serlinMoran meirJohn laceyPrnewswire biolinerx ltdLifesci advisorsBiolinerx ltdHold conference callChief executiveSci advisors

BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification

BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Tel avivUnited statesJohn laceyMoran meirNasdaq stock marketTel aviv stock exchangeCompany american depositary shares adssLifesci advisorsExchange commission onPrnewswire biolinerx ltdCompany nasdaqCompany adssBiolinerx ltdNasdaq listing rulesNasdaq capital marketAmerican depositary shares

BioLineRx : Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER .

United statesIsrael generalNew yorkGeorgia world congress centerJohn laceyTwitterand linkedinMoran meirJeffreyr skaarPhilipa serlinLifesci advisorsInternational society for pharmacoeconomicsOutcomes researchExchange commission onSecurities exchangeValue in healthSociety for health economics